131

Breast carcinoma (90 cases), infiltrating ductal carcinoma.

Breast carcinoma tissue array (30 cases), mainly invasive ductal carcinoma

Breast carcinoma tissue array, 145 cases, 1 core/case. Clinical stage 0, I, II, III. With survival data. Replacing HBre-Duc150Sur-02 (141 same cases)

Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by BR246

Breast carcinoma tissue array, with stage and grade info, 24 cases/72 cores, replacing BC08015

Breast carcinoma, 139 cases.

Breast carcinoma, 140 cases.

Breast carcinoma, 140 cases. 1 core/case with survival data

Breast carcinoma, 145 cases.

Breast disease spectrum (breast cancer progression) tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 192 cases/192 cores, replacing BR2082a

Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 20 cases/ 20 cores

Breast disease tissue array, 18 cases/18 cores

Breast ductal intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores

Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases/80 cores

Breast fibroadenoma tissue array, 30 cases/ 60 cores, replacing BR601

Breast hyperplasia tissue array, 80 cases/80 cores

Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores

Breast invasive ductal carcinoma (62 cases) and NAT.

Breast invasive ductal carcinoma tissue array (52 cases)

Breast invasive ductal carcinoma tissue array (64 cases) and other types of breast carcinoma (4 cases)

Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases/48 cores

Breast invasive ductal carcinoma tissue array, 31 cases. Tumor and matched normal adjacent tissue

Breast invasive ductal carcinoma tissue array, 40 cases, 3 cases with normal adjacent tissue. NAT.

Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases/100 cores, replacing BC08118

Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing BR808, BC08014

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing BR246a

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1505d

Breast invasive ductal carcinoma tissue array, with cancer adjacent breast tissue and adjacent normal breast tissue, including pathology grade,TNM and clinical stage, 21 cases/63 cores,replacing...

Breast invasive ductal carcinoma tissue microarray (75 cases), replacing HBre-Duc068Bch-01. ER, PR, Her2 available

Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases/80cores, replacing BR802

Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases/80 cores

Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores

Breast mastitis tissue array, 20 cases/ 40 cores

Breast mastitis tissue array, 20 cases/40 cores

Breast medullary carcinoma tissue array, including TNM, clinical stage, 24 cases/ 24 cores

Breast tissue array, 4 cases/4 cores

Breast tissue array, normal adjacent tissue of HBre-Duc170Sur-01, 90 cases. 1 core/case, with survival information

Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (24 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores

Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor tissue array (10 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (11 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (12 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (13 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (14 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (15 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (16 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (17 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (18 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (19 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (20 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (3 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (4 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (5 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (6 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (7 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (8 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (9 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases/72 cores

Breast various pathology developmental process tissue array, including TNM, clinical stage and pathology grade, 48cases/48 cores,replacing BR480

Carcinoma of large intestine tissue array

Carcinoma with adjacent-tissue combined panel tissue array, 44 cases/48 cores

Cardiovascular disease tissue array, including TNM and clinical stage, 24 cases/48 cores

Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases/48 cores

Cardiovascular disease tissue array, non-overlapping with CVD481, 23 cases/23 cores

Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases/208 cores

Cerebrum cancer tissue array, with normal tissue, including pathology grade, 2 serial sections, 6 cases/ 24 cores, replacing T173a

Cervical cancer and normal tissue array with TNM and grade, 40 cases/80 cores

Cervical cancer and normal tissue array with TNM and grade, 50 cases/50 cores,replaced by CR501a

Cervical cancer and normal tissue array, non-overlapping with CXC961, 48 cases/96 cores

Cervical cancer and normal tissue array, non-overlapping with CXC962, 48 cases/96 cores

Cervical cancer mid-density tissue array, 75 cases/150 cores

Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases/24 cores, replaced by T103a

Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by CR245a

Cervical cancer tissue array with normal tissues from autopsy, 40 cases/80 cores, with grade and TNM data

Cervical cancer tissue array, 12 cases/24 cores

Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores

Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases/80 cores

Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases/70 cores

Cervical intraepithelial neoplasia and cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores

Cervix adenocarcinoma with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage , 22 cases/24 cores

Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases/48 cores

Cervix cancer and normal tissue array with CIN and metastatic carcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores

Cervix cancer and normal tissue array, 16 cases/48 cores

Cervix cancer and normal tissue array, with stage and grade info, 80 cases/80 cores

Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases/208 cores